Swiss National Bank’s Arcturus Therapeutics ARCT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-47,700
| Closed | -$505K | – | 2338 |
|
2025
Q1 | $505K | Hold |
47,700
| – | – | ﹤0.01% | 2337 |
|
2024
Q4 | $809K | Hold |
47,700
| – | – | ﹤0.01% | 2292 |
|
2024
Q3 | $1.11M | Hold |
47,700
| – | – | ﹤0.01% | 2170 |
|
2024
Q2 | $1.16M | Buy |
47,700
+500
| +1% | +$12.2K | ﹤0.01% | 2105 |
|
2024
Q1 | $1.59M | Hold |
47,200
| – | – | ﹤0.01% | 1964 |
|
2023
Q4 | $1.49M | Sell |
47,200
-5,400
| -10% | -$170K | ﹤0.01% | 2010 |
|
2023
Q3 | $1.34M | Buy |
52,600
+500
| +1% | +$12.8K | ﹤0.01% | 2077 |
|
2023
Q2 | $1.49M | Buy |
52,100
+700
| +1% | +$20.1K | ﹤0.01% | 2075 |
|
2023
Q1 | $1.23M | Sell |
51,400
-6,300
| -11% | -$151K | ﹤0.01% | 2128 |
|
2022
Q4 | $979K | Buy |
57,700
+1,800
| +3% | +$30.5K | ﹤0.01% | 2357 |
|
2022
Q3 | $828K | Hold |
55,900
| – | – | ﹤0.01% | 2419 |
|
2022
Q2 | $880K | Buy |
55,900
+6,000
| +12% | +$94.5K | ﹤0.01% | 2438 |
|
2022
Q1 | $1.35M | Buy |
49,900
+3,600
| +8% | +$97K | ﹤0.01% | 2257 |
|
2021
Q4 | $1.71M | Hold |
46,300
| – | – | ﹤0.01% | 2164 |
|
2021
Q3 | $2.21M | Hold |
46,300
| – | – | ﹤0.01% | 1992 |
|
2021
Q2 | $1.57M | Buy |
46,300
+1,500
| +3% | +$50.8K | ﹤0.01% | 2257 |
|
2021
Q1 | $1.85M | Buy |
44,800
+700
| +2% | +$28.9K | ﹤0.01% | 2044 |
|
2020
Q4 | $1.91M | Buy |
44,100
+800
| +2% | +$34.7K | ﹤0.01% | 1929 |
|
2020
Q3 | $1.86M | Buy |
43,300
+10,000
| +30% | +$429K | ﹤0.01% | 1759 |
|
2020
Q2 | $1.56M | Buy |
+33,300
| New | +$1.56M | ﹤0.01% | 1850 |
|